SCHEMBL23775902

SCHEMBL23775902

Cc1ccc(S(=O)(=O)N2CC=C(C(=O)OC(C)(C)C)C2c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 2/20 0.47
GAA P10253 1/20 0.47
MMP2 P08253 2/20 0.46
LMNA P02545 2/20 0.45
CRHBP P24387 3/20 0.44
CRHR2 Q13324 3/20 0.44
USP2 O75604 5/20 0.44
MAPT P10636 1/20 0.42
KDM4A O75164 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
ANPEP P15144 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5161114 0.89 LMNA (0.52) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL4939764 0.87 TSHR (0.57) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL5163665 0.87 TSHR (0.57) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL23775984 0.87 TSHR (0.57) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL23757987 0.86 CRHBP (0.58) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL23757669 0.86 CRHBP (0.58) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL23757665 0.86 CRHBP (0.58) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL25491398 0.84 NPSR1 (0.53) NPSR1L3MBTL1TSHRGAAMMP2
SCHEMBL23776239 0.82 TSHR (0.52) NPSR1L3MBTL1TSHRGAALMNA
SCHEMBL25491397 0.82 NPSR1 (0.51) NPSR1L3MBTL1TSHRGAAMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-18 US disclosed
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-18 US disclosed
WO-2021163493-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150935-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS CHERP, ATP2A1, ATP2A3 NPSR1 2176/4885L3MBTL1 2702/4885TSHR 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.